Updated Jul 16, 2026
WEATHERMAN ELIZABETH H has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $497K.
Elizabeth H. Weatherman is a corporate director known for her roles at various biopharmaceutical companies, including Royalty Pharma plc and Nevro Corp. She has participated in SEC filings related to her directorships but is not widely recognized in public domains.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | RPRX | Royalty Pharma plc | A — Grant or award | 4.5K | $0.00 | |
| 2026-06-03 | PODD | INSULET CORP | P — Open-market purchase | 3.5K | $144.20 | $497K |
| 2026-05-21 | PODD | INSULET CORP | A — Grant or award | 1.7K | $0.00 | |
| 2025-07-31 | RPRX | Royalty Pharma plc | A — Grant or award | 5.8K | $0.00 | |
| 2025-07-31 | RPRX | Royalty Pharma plc | A — Grant or award | 2.8K | $0.00 | |
| 2025-05-22 | PODD | INSULET CORP | A — Grant or award | 778 | $0.00 | |
| 2025-04-03 | NVRO | NEVRO CORP | D — Derivative transaction | 86.2K | — | |
| 2024-10-02 | NVRO | NEVRO CORP | A — Grant or award | 3.5K | $0.00 |
Elizabeth H. Weatherman is a corporate director known for her roles at various biopharmaceutical companies, including Royalty Pharma plc and Nevro Corp. She has participated in SEC filings related to her directorships but is not widely recognized in public domains.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($497K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live WEATHERMAN ELIZABETH H profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.